Judges named for 2022 Houston Innovation Awards

in the hot seat

Here's who's making the call for this year's Houston Innovation Awards. Photos courtesy

Nominations are closed, applications are out, and the city of Houston is waiting to see who are the finalists for the 2022 Houston Innovation Awards. But first — who are tasked with the job of deciding the honorees for the Houston Innovation Awards Gala on November 9?

Click here to secure your tickets to the event.

A cohort of eight of the best innovation leaders in the Bayou City — representing all corners of tech and innovation, from energy and hard tech to software and startup acceleration. Introducing: The 2022 Houston Innovation Awards judges:

Carolyn Rodz, founder and CEO of Hello Alice

Carolyn Rodz, founder and CEO of Hello Alice

Photo courtesy of Hello Alice

Carolyn Rodz is a leader in Houston innovation — both as a startup founder and as a resources for startups and small businesses across the country. As CEO, she leads Hello Alice, a company Rodz founded with Elizabeth Gore, on its mission to provide support and guidance to small business owners.

Rodz is no stranger to InnovationMap's awards program. Last year, Hello Alice was a finalist in three categories and took home the win for BIPOC-owned business.

Wogbe Ofori, founder of Wrx Companies

Photo courtesy

​Wogbe Ofori is a champion of Houston innovation, startup mentor, investor, and more. He's particularly passionate about hard tech and serves as an adviser to Houston-based Nauticus Robotics and CaringBand. He also participates as a mentor across several organizations, including MassChallenge, Capital Factory, Founder Institute, and the University of Houston.

Scott Gale, executive director of Halliburton Labs

Photo courtesy

After several years in strategy at Halliburton, Scott Gale switched gears to lead Halliburton Labs, which launched in 2020. The startup incubation lab focuses on supporting early-stage companies within climatetech and the future of energy.

Ashley Danna, senior manager of regional economic development of Greater Houston Partnership

Photo courtesy

It's Ashley Danna's job at GHP to have a pulse on companies in Houston — including tech and life science businesses. Her role is focused on marketing the Houston region as a business magnet to expanding and relocating domestic businesses to foster job creation and economic growth while collaborating and strengthening relationships with external stakeholders.

Kelly McCormick, professor at the University of Houston

Photo courtesy

Kelly McCormick has spent the better part of a decade molding young, entrepreneurial minds at the University of Houston, both as a professor and as leading UH's student startup accelerator, Red Labs.

Paul Cherukuri, vice president of innovation at Rice University

Photo courtesy of Rice

Paul Cherukuri, the executive director of the Institute of Biosciences and Bioengineering, was named the inaugural vice president for innovation at Rice University in August. In his role, Cherukuri leads Rice’s technology and commercialization infrastructure to translate breakthrough discoveries into inventions for the benefit of society.

Lawson Gow, CEO of Houston Exponential

Photo courtesy of The Cannon

Lawson Gow wears many hats within the Houston innovation ecosystem. He founded The Cannon, a Houston-wide coworking company, and now oversees Houston Exponential. He also is the founder and CEO of sportstech-focused Pokatok and chief strategy officer of SportsMap SPAC.

Natalie Harms, editor of InnovationMap

Photo courtesy

Natalie Harms has been at the helm of InnovationMap — Houston's voice for Innovation — since its inception in October 2018. She oversees all editorial operations of the site and hosts its weekly podcast, the Houston Innovators Podcast.

From Your Site Articles
Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Houston clean hydrogen startup to pilot tech with O&G co.

stay gold

Gold H2, a Houston-based producer of clean hydrogen, is teaming up with a major U.S.-based oil and gas company as the first step in launching a 12-month series of pilot projects.

The tentative agreement with the unnamed oil and gas company kicks off the availability of the startup’s Black 2 Gold microbial technology. The technology underpins the startup’s biotech process for converting crude oil into proprietary Gold Hydrogen.

The cleantech startup plans to sign up several oil and gas companies for the pilot program. Gold H2 says it’s been in discussions with companies in North America, Latin America, India, Eastern Europe and the Middle East.

The pilot program is aimed at demonstrating how Gold H2’s technology can transform old oil wells into hydrogen-generating assets. Gold H2, a spinout of Houston-based biotech company Cemvita, says the technology is capable of producing hydrogen that’s cheaper and cleaner than ever before.

“This business model will reshape the traditional oil and gas industry landscape by further accelerating the clean energy transition and creating new economic opportunities in areas that were previously dismissed as unviable,” Gold H2 says in a news release.

The start of the Black 2 Gold demonstrations follows the recent hiring of oil and gas industry veteran Prabhdeep Singh Sekhon as CEO.

“With the proliferation of AI, growth of data centers, and a national boom in industrial manufacturing underway, affordable … carbon-free energy is more paramount than ever,” says Rayyan Islam, co-founder and general partner at venture capital firm 8090 Industries, an investor in Gold H2. “We’re investing in Gold H2, as we know they’ll play a pivotal role in unleashing a new dawn for energy abundance in partnership with the oil industry.”

------

This article originally ran on EnergyCapital.

3 Houston innovators to know this week

who's who

Editor's note: Every week, I introduce you to a handful of Houston innovators to know recently making headlines with news of innovative technology, investment activity, and more. This week's batch includes an e-commerce startup founder, an industrial biologist, and a cellular scientist.

Omair Tariq, co-founder and CEO of Cart.com

Omair Tariq of Cart.com joins the Houston Innovators Podcast to share his confidence in Houston as the right place to scale his unicorn. Photo via Cart.com

Houston-based Cart.com, which operates a multichannel commerce platform, has secured $105 million in debt refinancing from investment manager BlackRock.

The debt refinancing follows a recent $25 million series C extension round, bringing Cart.com’s series C total to $85 million. The scaleup’s valuation now stands at $1.2 billion, making it one of the few $1 billion-plus “unicorns” in the Houston area.

Cart.com was co-founded by CEO Omair Tariq in October 2020. Read more.

Nádia Skorupa Parachin, vice president of industrial biotechnology at Cemvita

Nádia Skorupa Parachin joined Cemvita as vice president of industrial biotechnology. Photo courtesy of Cemvita

Houston-based biotech company Cemvita recently tapped two executives to help commercialize its sustainable fuel made from carbon waste.

Nádia Skorupa Parachin came aboard as vice president of industrial biotechnology, and Phil Garcia was promoted to vice president of commercialization.

Parachin most recently oversaw several projects at Boston-based biotech company Ginkjo Bioworks. She previously co-founded Brazilian biotech startup Integra Bioprocessos. Read more.

Han Xiao, associate professor of chemistry at Rice University

The funds were awarded to Han Xiao, a chemist at Rice University.

A Rice University chemist has landed a $2 million grant from the National Institute of Health for his work that aims to reprogram the genetic code and explore the role certain cells play in causing diseases like cancer and neurological disorders.

The funds were awarded to Han Xiao, the Norman Hackerman-Welch Young Investigator, associate professor of chemistry, from the NIH's Maximizing Investigators’ Research Award (MIRA) program, which supports medically focused laboratories. Xiao will use the five-year grant to advance his work on noncanonical amino acids.

“This innovative approach could revolutionize how we understand and control cellular functions,” Xiao said in the statement. Read more.

Houston chemist lands $2M NIH grant for cancer treatment research

future of cellular health

A Rice University chemist has landed a $2 million grant from the National Institute of Health for his work that aims to reprogram the genetic code and explore the role certain cells play in causing diseases like cancer and neurological disorders.

The funds were awarded to Han Xiao, the Norman Hackerman-Welch Young Investigator, associate professor of chemistry, from the NIH's Maximizing Investigators’ Research Award (MIRA) program, which supports medically focused laboratories.

Xiao will use the five-year grant to develop noncanonical amino acids (ncAAs) with diverse properties to help build proteins, according to a statement from Rice. He and his team will then use the ncAAs to explore the vivo sensors for enzymes involved in posttranslational modifications (PTMs), which play a role in the development of cancers and neurological disorders. Additionally, the team will look to develop a way to detect these enzymes in living organisms in real-time rather than in a lab.

“This innovative approach could revolutionize how we understand and control cellular functions,” Xiao said in the statement.

According to Rice, these developments could have major implications for the way diseases are treated, specifically for epigenetic inhibitors that are used to treat cancer.

Xiao helped lead the charge to launch Rice's new Synthesis X Center this spring. The center, which was born out of informal meetings between Xio's lab and others from the Baylor College of Medicine’s Dan L Duncan Comprehensive Cancer Center at the Baylor College of Medicine, aims to improve cancer outcomes by turning fundamental research into clinical applications.

They will build upon annual retreats, in which investigators can share unpublished findings, and also plan to host a national conference, the first slated for this fall titled "Synthetic Innovations Towards a Cure for Cancer.”

View All Listings